The effects of lipid extraction on the immunomodulatory activity of Malassezia species in vitro

Medical Mycology

Volumn 38, Issue 3, 2000, Pages 239-247

  Kesavan, S ^a   Holland, K T ^a   Ingham, Eillen ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Lipid extracted yeast cell; Malassezia; Peripheral blood mononuclear cell; Pro inflammatory cytokine

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACTION; HUMAN; IMMUNOMODULATION; INFLAMMATORY CELL; MALASSEZIA; MONONUCLEAR CELL; NONHUMAN; SEBORRHEIC DERMATITIS; YEAST;

MALASSEZIA; MALASSEZIA SYMPODIALIS; PITYRIASIS;

EID: 0034084230     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.38.3.239.247     Document Type: Article

References (41)

1. Yarrow D, Ahearn DG, Malassezia Baillon. In: Kreger-Van Rij NJW. ed. The Yeasts: A Taxonomic Study. 3rd edn. Amsterdam: North Holland Publishing Company, 1984: 882-885.
2. Guého E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie van Leeuwenhoek 1996; 69: 337-355.
3. Keddie FM. Electron microscopy of Malassezia furfur in tinea versicolor. Sabouradia 1967; 5: 134-137.
4. Webster GF. Seborrhoeic dermatitis. Int J Dermatol 1991; 30: 843-844.
5. Back O, Faergemann J, Hornqvist N. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol 1985; 12: 56-61.
6. McGinley KJ, Leyden LJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff and seborrhoeic dermatitis. J Invest Dermatol 1975; 64: 401-406.
7. Clemmenssen OJ, Hjorth N. Treatment of dermatitis of the head and neck with ketoconazole in patients with Type 1 hypersensitivity for P. orbiculare. Semin Dermatol 1983; 2: 26-29.
8. Marcon MJ, Powell DA. Epidemiology, diagnosis and management of Malassezia furfur systemic infection. Diag Microbiol Infect Dis 1987; 7: 161-175.
9. Buffill JA, Lum LG, Caya JG, et al. Pityrosporum folliculitis after bone marrow transplantation. Ann Intern Med 1988; 108: 560-563.
10. Segal R, Shuveli D, Yussim A, Sandback M, Alteras I, Shapira Z. Renal transplant incidence of superficial fungal infection as related to immunosuppressive therapy. Transplant Proc 1989; 21: 2114-2116.
11. Vidal C, Girard P-M, Dompmartin D, et al. Seborrhoeic dermatitis and HIV infection. J Am Acad Dermatol 1990; 23: 1106-1110.
12. Sohnle PG, Collins-Lech C. Cell mediated immunity to Pityrosporum orbiculare in tinea versicolor. J Clin Invest 1978; 62: 45-53.
13. Sohnle PG, Collins-Lech C. Analysis of the lymphocyte transformation response to Pityrosporum orbiculare in patients with tinea versicolor. Clin Exp Immunol 1982; 49: 559-564.
14. Wu Y-C, Chen K-T. Lymphocyte proliferation to crude extract of Pityrosporum species and natural killer activity in tinea versicolor. J Med Assoc Thailand 1987; 70: 45.
15. Ashbee HR, Ingham E, Holland KT, Cunliffe WJ. Cell-mediated immune responses to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Exp Dermatol 1994; 3: 106-112.
16. Damert GJ, Kirkpatrick CH, Sohmle PG. Comparison of antibody responses in chronic mucocutaneous candidiasis and tinea versicolor. Int Arch Allergy App Immunol 1980; 63: 97-104.
17. Wu Y-C, Chen K-T. Humoral immunity in patients with tinea versicolor. J Dermatol (Tokyo) 1985; 12: 161-166.
18. Hay RJ, Midgley G. Pathogenic mechanisms of Pityrosporum infection. In: Shuster S, Blatchford N, eds. Seborrhoeic Dermatitis and Dandruff - A Fungal Disease. London: Royal Society of Medicine International Congress and Symposium Series (No. 132). Royal Society of Medicine Services Limited. 1988: 13-19.
19. Berbgrant I-M, Johansson S, Robbins D, Scheynius A, Faergemann J, Soderstrom T. An immunological study in patients with seborrhoeic dermatitis. Clin Exp Dermatol 1991; 16: 331-338.
20. Cunningham AC, Ingham E, Gowland DG. Humoral responses to Malassezia furfur serovars A, B and C in normal individuals of various ages. Br J Dermatol 1992; 127: 476-481.
21. Ashbee HR, Fruin A, Holland KT, Cunliffe WJ, Ingham E. Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Exp Dermatol 1994; 3: 1-7.
22. Kesavan S, Walters CE, Holland KT, Ingham E. The effects of Malassezia on pro-inflammatory cytokine production by human peripheral blood mononuclear cells in vitro. Med Mycol 1998; 36: 97-106.
23. Hechemy KE, Vanderwyk RW. Isolation, purification and chemical analysis of Pityrosporum ovale cell wall. Bacteriol Proc 1968; 68: 42.
24. Thompson E, Colvin JR. Composition of the cell wall of Pityrosporum ovale (Bizzozero) Castellani and Chalmers. Can J Microbiol 1970; 16: 263-265.
25. Mittag H. Fine structural investigation of Malassezia furfur. II. The envelope of the yeast cells. Mycoses 1995; 38: 13-21.
26. Leeming JP, Notman FH. Improved methods for the isolation and enumeration of Malassezia furfur from human skin. J Clin Microbiol 1987; 25: 2017-2019.
27. Cunningham AC, Leeming JP, Ingham E, Gowland G. Differentiation of three serovars of Malassezia furfur. J Appl Bacteriol 1990; 68: 439-446.
28. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
29. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55-63.
30. Sokal RR, Rohlf FJ. In: Wilson J, Cotter S, eds. Biometry. The Principles and Practice of Statistics in Biological Research. 2nd edn. New York: W.H. Freeman and Company, 1981: 128-371.
31. Winiarczyk S. The ultrastructure of Pityrosporum pachydermatis. Arch Vet Pol 1992; 32: 5-11.
32. Ashbee HR, Alvarado-Alvarez ZL, Whitehead Z, Evans EGV. Phagocytic uptake and killing of Malassezia-the role of the capsule. Proceedings of the Fourth Congress of the European Confederation of Medical Mycology (ECMM), Glasgow, Scotland, 1998, Abstract.
33. Kozel TR, Pfrommer GS, Guerlain AS, Highison BA, Highison GJ. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev Infect Dis 1988: 10: 436-439.
34. Vecchiarelli A, Retini C, Pietrella D, et al. Down-regulation by cryptococcal polysaccharide of tumour necrosis factor alpha and interleukin-1β secretion from human monocytes. Infect Immun 1995; 63: 2919-2923.
35. Cross CE, Bancroft GJ. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun 1995; 63: 2604-2611.
36. Stahl P. The macrophage mannose receptor and other macrophage lectins. Curr Opin Immunol 1992; 4: 49-52.
37. Kay J, Czop JK. Enhancement of human monocyte β-glucan receptors by glucocorticoids. Immunology 1994; 81: 96-102.
38. Holt P, Holmskov U, Theil S, Teisner B, Hojrup P, Jensenius C. Purification and characterisation of mannan-binding protein from mouse serum. Scand J Immunol 1994; 39: 202-208.
39. Ezekowitz RAB, Sastry K, Bailly P, Warner A. Molecular characterisation of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeast cells in Cos-1 cells. J Exp Med 1990; 172: 1785-1794.
40. Gloor M, Wiegand I, Friedrich HC. Uber Menge und Zusammensetzung der Hautoflachenlipide beim soganannten seborrhoischen Ekzem. Dermatologische Monatsschrift 1972; 158: 759-764.
41. Walters CE, Ingham E, Eady EA, Cove JH, Kearney JN, Cunliffe WJ. In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1α) and peripheral blood mononucleur cell-derived IL-1β release in response to cutaneous commensal microorganisms. Infect Immun 1995; 63: 1223-1228.